The pipeline of new biologic drugs for autoimmune diseases and cancer is expected to cause a massive explosion in drug costs.

“if you look at the pipeline of drugs for the next 10 years I've done this right like look at the pfal list or whatever at the FTA the number of unique biologic infusible drugs in particular for autoimmune disease and cancer that are slated to go through the process and get approved which again not having seen the data it's hard to know whether they'll transform the care of those diseases or marginally improve them but if they get approved they'll be doing some benefit will create another massive explosion of drug cost here”